Mapping Longevity Pathways Through Mitochondrial Dysfunction: Roles of the Microbiome and Metabolism in Aging
2024
Mapping Longevity Pathways Through Mitochondrial Dysfunction
publication
Author Information
Author(s): Bitto Alessandro
Primary Institution: University of Washington, Seattle, Washington, United States
Hypothesis
Longevity interventions may be applied to chronic diseases characterized by failure of one or more of these fundamental biological processes, regardless of biological age.
Conclusion
The study investigates how longevity interventions affect metabolism and intestinal flora in the context of mitochondrial dysfunction.
Supporting Evidence
- The study explores the impact of longevity interventions on chronic mitochondrial disease.
- Fatty acid metabolism plays a critical role in treating mitochondrial disease.
- Models of chronic disease can help study longevity pathways.
Takeaway
This study looks at how certain drugs might help with aging and diseases by improving how our cells work.
Methodology
The study uses a mitochondrial dysfunction model to investigate the effects of the antidiabetic drug acarbose and the mTOR inhibitor rapamycin.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website